Agile Therapeutics, Inc.
(OTC: AGRX)
Rigrodsky Law, P.A. is investigating Agile Therapeutics, Inc. (“Agile”) regarding possible breaches of fiduciary duties and other violations of law related to Agile’s agreement to be acquired by Insud Pharma, S.L. Under the terms of the agreement, Agile shareholders will receive $1.52 per share in cash.